RNA expressions of AHR, ARNT and CYP1B1 are influenced by AHR Arg554Lys polymorphism

Molecular Genetics and Metabolism

Volumn 104, Issue 1-2, 2011, Pages 180-184

  Helmig, Simone ^a   Seelinger, Jens Udo ^a   Döhrel, Juliane ^a   Schneider, Joachim ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

AHR gene expression; AHR gene polymorphism; ARNT gene expression; Aryl hydrocarbon receptor; CYP1B1 gene expression; Hydrocarbon Receptor Nuclear Translocator

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1B1; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; RNA;

ADULT; AGED; ARTICLE; CALCULATION; CAUCASIAN; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE REPLICATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HOMOZYGOTE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; ARYL HYDROCARBON HYDROXYLASES; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; YOUNG ADULT;

EID: 80052536176     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.06.009     Document Type: Article

References (36)

1. van den Berg M., Peterson R.E., Schrenk D. Human risk assessment and TEFs. Food Addit. Contam. 2000, 17(4):347-358.
2. Bock K.W., Kohle C. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem. Pharmacol. 2006, 72(4):393-404.
3. Poland A., Knutson J.C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 1982, 22:517-554.
4. Gasiewicz T.A., Rucci G. Cytosolic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Evidence for a homologous nature among various mammalian species. Mol. Pharmacol. 1984, 26(1):90-98.
5. Connor K.T., Aylward L.L. Human response to dioxin: aryl hydrocarbon receptor (AhR) molecular structure, function, and dose-response data for enzyme induction indicate an impaired human AhR. J. Toxicol. Environ. Health B Crit. Rev. 2006, 9(2):147-171.
6. Kalmes M., Hennen J., Clemens J., Blomeke B. Impact of aryl hydrocarbon receptor (AhR) knockdown on cell cycle progression in human HaCaT keratinocytes. Biol. Chem. 2011, 392(7):643-651.
7. Barhoover M.A., Hall J.M., Greenlee W.F., Thomas R.S. Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4. Mol. Pharmacol. 2010, 77(2):195-201.
8. Puga A., Ma C., Marlowe J.L. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem. Pharmacol. 2009, 77(4):713-722.
9. Rowlands C.J., Staskal D.F., Gollapudi B., Budinsky R. The human AHR: identification of single nucleotide polymorphisms from six ethnic populations. Pharmacogenet. Genomics 2010, 20(5):283-290.
10. Harper P.A., Wong J.Y., Lam M.S., Okey A.B. Polymorphisms in the human AH receptor. Chem. Biol. Interact. 2002, 141(1-2):161-187.
11. Chen D., Tian T., Wang H., Liu H., Hu Z., Wang Y., et al. Association of human aryl hydrocarbon receptor gene polymorphisms with risk of lung cancer among cigarette smokers in a Chinese population. Pharmacogenet. Genomics 2009, 19(1):25-34.
12. Sangrajrang S., Sato Y., Sakamoto H., Ohnami S., Laird N.M., Khuhaprema T., et al. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int. J. Cancer 2009, 125(4):837-843.
13. Chen Y., Bai Y., Yuan J., Chen W., Sun J., Wang H., et al. Association of polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers. Cancer Epidemiol. Biomarkers Prev. 2006, 15(9):1703-1707.
14. Hayashi S., Watanabe J., Nakachi K., Eguchi H., Gotoh O., Kawajiri K. Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 1994, 15(5):801-806.
15. Lin P., Hu S.W., Chang T.H. Correlation between gene expression of aryl hydrocarbon receptor (AhR), hydrocarbon receptor nuclear translocator (Arnt), cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and inducibility of CYP1A1 and CYP1B1 in human lymphocytes. Toxicol. Sci. 2003, 71(1):20-26.
16. Helmig S., Hadzaad B., Dohrel J., Schneider J. Relative quantification of Cytochrome P450 1B1 gene expression in peripheral leukocytes using lightcycler. Cancer Genomics Proteomics 2009, 6(1):13-17.
17. Zhang X., Ding L., Sandford A.J. Selection of reference genes for gene expression studies in human neutrophils by real-time PCR. BMC Mol. Biol. 2005, 6(1):4.
18. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3(7). p. RESEARCH0034.
19. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29(9):e45.
20. Helmig S., Hadzaad B., Dohrel J., Schneider J. Influence of the Cyp1B1 L432V gene polymorphism and exposure to tobacco smoke on Cyp1B1 mRNA expression in human leukocytes. Drug Metab. Dispos. 2009, 37(7):1490-1495.
21. Nebert D.W., Dalton T.P., Okey A.B., Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 2004, 279(23):23847-23850.
22. Barouki R., Coumoul X., Fernandez-Salguero P.M. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett. 2007, 581(19):3608-3615.
23. Birnbaum L.S., McDonald M.M., Blair P.C., Clark A.M., Harris M.W. Differential toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J mice congenic at the Ah Locus. Fundam. Appl. Toxicol. 1990, 15(1):186-200.
24. Pohjanvirta R., Tuomisto J. Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol. Rev. 1994, 46(4):483-549.
25. Pohjanvirta R., Wong J.M., Li W., Harper P.A., Tuomisto J., Okey A.B. Point mutation in intron sequence causes altered carboxyl-terminal structure in the aryl hydrocarbon receptor of the most 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant rat strain. Mol. Pharmacol. 1998, 54(1):86-93.
26. Celius T., Matthews J. Functional analysis of six human aryl hydrocarbon receptor variants in human breast cancer and mouse hepatoma cell lines. Toxicology 2010, 277(1-3):59-65.
27. van Duursen M.B., Sanderson J.T., van den Berg M. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility. Toxicol. Sci. 2005, 85(1):703-712.
28. Wong J.M., Okey A.B., Harper P.A. Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction. Biochem. Biophys. Res. Commun. 2001, 288(4):990-996.
29. Pitt J.A., Feng L., Abbott B.D., Schmid J., Batt R.E., Costich T.G., et al. Expression of AhR and ARNT mRNA in cultured human endometrial explants exposed to TCDD. Toxicol. Sci. 2001, 62(2):289-298.
30. Abbott B.D., Held G.A., Wood C.R., Buckalew A.R., Brown J.G., Schmid J. AhR, ARNT, and CYP1A1 mRNA quantitation in cultured human embryonic palates exposed to TCDD and comparison with mouse palate in vivo and in culture. Toxicol. Sci. 1999, 47(1):62-75.
31. Siest G., Jeannesson E., Marteau J.B., Samara A., Marie B., Pfister M., et al. Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects. Drug Metab. Dispos. 2008, 36(1):182-189.
32. Helmig S., Seelinger J.U., Philipp-Gehlhaar M., Dohrel J., Schneider J. Cyp1B1 mRNA expression in correlation to cotinine levels with respect to the Cyp1B1 L432V gene polymorphism. Eur. J. Epidemiol. 2010, 25(12):867-873.
33. Kawajiri K., Watanabe J., Eguchi H., Nakachi K., Kiyohara C., Hayashi S. Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 1995, 5(3):151-158.
34. Tsuchiya M., Katoh T., Motoyama H., Sasaki H., Tsugane S., Ikenoue T. Analysis of the AhR, ARNT, and AhRR gene polymorphisms: genetic contribution to endometriosis susceptibility and severity. Fertil. Steril. 2005, 84(2):454-458.
35. Le Marchand L., Donlon T., Kolonel L.N., Henderson B.E., Wilkens L.R. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev. 2005, 14(8):1998-2003.
36. Mimura J., Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim. Biophys. Acta 2003, 1619(3):263-268.